English

• During the past decades, transition-metal catalyzed cascade C-H activation/annulation reaction has clearly served as an efficient method in synthetic chemistry [1-6] to construct diverse heterocycles such as isoquinolines [7], quinazolines [8], naphthalenone [9], naphthols [10] and others [11-24]. And this method has been well explored by numerous chemists because of its simple operation, fewer synthetic steps, high atom economy and high regioselectivity.

  On the other hand, 1-aminoisoquinolines are frequently found in many drug molecules (Fig. 1) and exhibit a wide range of biological and pharmaceutical activities [25-31]. Therefore, straightforward strategy to access 1-aminoisoquinolines has intensively intrigued the scientists. According literatures, many methods have been reported including the coupling reaction of 1-aminoisoquinoline with phenylboronic acid [32], the transformation of 1-chloroisoquinoline with amine [33-35], and the amination between isoquinoline-N-oxide with amines [36-42], phenyl isothiocyanate [43]. Besides, benzamidines are efficient directing groups [44-53], which have been widely employed for the construction of 1-aminoisoquinolines derivatives via C-H activation/annulation adopting different C2 synthons, such as α-OMs/OTs acetophenone [54], diazo compounds [55-57], allyl carbonates [58], alkynes [59, 60] and sulfoxonium ylides (Scheme 1a) [61, 62]. However, all of these transformations only provided the aminoisquinolines with R₂ or R₃ (phenyl or alkyl), and the construction of nonsubstituted aminoisquinoline skeletons (R₂, R₃ = H) were seldom disclosed through C-H activation.

  Figure 1

  

  Figure 1.  Selected examples of bioactive aminoisoquinolines.

  DownLoad: Full-Size Img PowerPoint

  Scheme 1

  

  Scheme 1.  Synthesis of aminoisoquinolines and other heterocycles via C-H activation/annulation.

  DownLoad: Full-Size Img PowerPoint

  Recently, vinylene carbonate, featuring higher operational security and commercial availability as acetylene surrogate, has been involved in the transition-metal-catalyzed C(sp²)-H activation reactions [63-66] by extruding a carbonate anion (Scheme 1b). In these cases, heterocyclic structures such as isoquinolinones and isocoumarins, have been successfully and efficiently synthesized utilizing vinylene carbonate as a new C2 synthon under Co(Ⅲ) or Rh(Ⅲ) catalysis with N-methoxybenzamide [67] or benzoic acid [68]. In this regard, we herein demonstrate a facile method to generate nonsubstituted aminoisoquinolines derivatives by a Rh(Ⅲ)-catalyzed cascade C-H activation/annulation reaction using benzimidamides with vinylene carbonate (Scheme 1c).

  We commenced the reaction of Rh(Ⅲ)-catalyzed [4 + 2] annulation reaction with N-(tert-butyl)benzimidamide (1a) and vinylene carbonate (2a) as model substrates. To our delight, we obtained the expected aminoisoquinolines products in 20% yields by employing [Cp*RhCl₂]₂ (5 mol%) and AgSbF₆ (20 mol%) as catalytic system in 1, 2-dichloroethane at 100 ℃ for 24 h under argon atmosphere (Table 1, entry 1). Initially, the yields of aminoisoquinolines did not increase when replacing the Rh catalyst with other metal catalysts (entries 2 and 3). Then several sliver salts were investigated, among which AgOTf gave the superior result compared with AgSbF₆, AgBF₄ and AgOTs (entries 4–6). In order to further increase the yield, different bases were screened including NaOAc, KPF₆, K₂CO₃, KOPiv, and the results revealed that KOPiv was the best base for this reaction (entries 7–10). Finally, the use of toluene significantly increased the yield to 79%, which revealed solvents have a significant impact on the conversion (entries 11–13). In conclusion, the optimal conditions are shown as follows: the reaction proceeded in 79% yield under [Cp*RhCl₂]₂ (5 mol%) and AgOTf (20 mol%), using KOPiv (20 mol%) as additives in Tol (2.0 mL) at 100 ℃ for 24 h under Ar.

  Table 1

  

  Table 1.  Optimization of reaction conditions.^a

  DownLoad: CSV

  With the optimized conditions in hand, we started to investigate the scope and generality of benzamidines derivatives for the [4 + 2] annulation reactions. Generally, benzamidines bearing electron-donating (Me, OMe, t-Bu) and electron-withdrawing groups (F, Cl, Br) on the benzene ring could generate aminoisoquinolines derivatives (Scheme 2, 3aa-3ha) smoothly by reacting with vinylene carbonate in moderate to good yields. As shown in Scheme 2, it was obvious that the yields of the transformation decreased dramatically to 33%–42% for ortho-substituent substrates (3na-3pa), which indicated that the transformation was tremendously influenced by steric hindrance effect. Besides, it was interesting to note that the substrates with diverse groups at the meta position demonstrated higher efficiencies than that at the para position on the whole. In addition, meta-methyl-, meta-cholro- and meta-bromo-substituted benzamidines preferred the site with less hindrance (3ia-3ka), while meta-methoxyl- and meta-fluoro-substituted reactants gave the two regioselective products (3la-3ma). Delightfully, the product was isolated in 90% yields when reactant with a thiophene ring was used. Moreover, substituent with naphthalene was also suitable for the reaction, albeit in a 58% yield. Furthermore, when tert-butyl is replaced by other alkyl groups such as benzyl, isopropyl and n-butyl, this cascade procedure could also convert to generate corresponding products in 42%–46% yields (3sa-3ua). However, the reaction failed to work when N-phenylbenzimidamide was added.

  Scheme 2

  

  Scheme 2.  Substrate scope of benzamidines. Reaction conditions: 1 (0.2 mmol), 2a (0.4 mmol), [Cp*RhCl₂]₂ (5 mol%), AgOTf (20 mol%), KOPiv (20 mol%), Toluene (1.5 mL), Ar, 100 ℃, 24 h.

  DownLoad: Full-Size Img PowerPoint

  Scheme 3

  

  Scheme 3.  Substrate scope of N-phenylbenzimidamides.

  DownLoad: Full-Size Img PowerPoint

  Due to the inert reactivity of N-phenylbenzimidamide, a series of reaction conditions were examined for realization of the conversion by employing vinylene carbonate (see Supporting information for details). Fortunately, we obtained the expected N-phenylisoquinolin-1-amine successfully and confirmed the optimal conditions that the reaction proceeded in 60% yield with [Cp*RhCl₂]₂ (5 mol%), AgOAc (20 mol%) and ZnSO₄·7H₂O (20 mol%) as catalytic system in chlorobenzene (2.0 mL) at 140 ℃ for 24 h under Ar (Scheme 3). The electron-donating and electron-withdrawing groups were all compatible in 45%–66% yields without obvious electrical effect. Unfortunately, when the benzene ring was replaced by thiophene ring or naphthalene, we did not observe obvious products.

  In order to explore whether the strategy could be applied for large scale, we enlarged the amount of 1a (2 mmol) and 2a (4 mmol) under the optimized conditions (Scheme 4). The result disclosed the transformation was less efficient in the yield of 55%.

  Scheme 4

  

  Scheme 4.  Ten-fold-scale synthesis of aminoisoquinolines.

  DownLoad: Full-Size Img PowerPoint

  To further explore the experimental mechanism, we completed some mechanistic experiments. The H/D exchange experiment was carried out by using 1b with CD₃OD at 100 ℃ for 2 h, which showed that 42% deuterium incorporation was estimated at ortho-position by ¹H NMR indicating C-H bond cleavage of the transformation was reversible (Scheme 5a). When equimolar amounts of 1b and 1e were added in intermolecular competition experiment, the 3ba and 3ea were obtained in a ratio of 1.5:1, which indicated that electron-donating group was more effective (Scheme 5b).

  Scheme 5

  

  Scheme 5.  Mechanistic studies.

  DownLoad: Full-Size Img PowerPoint

  Based on the above experiments and related literature, a plausible mechanism is presented in the Scheme 6. First, benzamidine transforms into a rhodacyclic intermediate A by C-H activation. Subsequently, the insertion of 2a with intermediate A results in the formation of seven-member intermediate B. Then, intermediate B undergoes reductive elimination to generate intermediate C releasing the Cp*Rh (I). The rhodium complexe D is obtained from oxidative addition of intermediate C and Cp*Rh (I). Finally, the rhodium complexe D generates aminoisoquinoline with the formation of the carbonate anion through β-oxygen elimination.

  Scheme 6

  

  Scheme 6.  Plausible reaction mechanism.

  DownLoad: Full-Size Img PowerPoint

  In conclusion, we developed a novel method to construct aminoisoquinolines derivatives via Rh(Ⅲ)-catalyzed C-H activation/annulation by coupling benzamidines with vinylene carbonate as an acetylene surrogate. In this work, we realized the transformations of phenyl and alkyl-substituted benzamidines in good to moderate yields under different conditions, which was applied for larger scale.

  Declaration of competing interest

  The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  Acknowledgment

  We are grateful for the support from the National Natural Science Foundation of China (NSFC, Nos. 81602954, 81573286, 81373259 and 81773577).

  Supplementary materials

  Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.cclet.2021.04.058.

  
  
• 1. [1]

     A. Baccalini, G. Faita, G. Zanoni, D. Maiti, Chem. Eur. J.26 (2020) 9749-9783 doi: 10.1002/chem.202001832

  2. [2]

     L. Song, E.V. Van der Eycken, Chem. Eur. J. 26 (2020) 1-25 doi: 10.1111/cwe.12349

  3. [3]

     M.R. Sk, S.S. Bera, S. Basuli, A. Metya, M.S. Maji, Asian J. Org. Chem. 9 (2020) 1701-1717 doi: 10.1002/ajoc.202000367

  4. [4]

     X. Huang, S. Liao, L. Xin, F. Zhang, Y. Yu, Synthesis 53 (2021) 238-254 doi: 10.1055/s-0040-1707268

  5. [5]

     Z. Wang, P. Xie, Y. Xia, Chin. Chem. Lett. 2018, 29, 47-53 doi: 10.11648/j.ajmsp.20180303.12

  6. [6]

     X. Han, P. Lin, Q. Li, Chin. Chem. Lett. 30 (2019) 1495-1502 doi: 10.1016/j.cclet.2019.04.027

  7. [7]

     Y.F. Wang, K.K. Toh, J.Y. Lee, S. Chiba, Angew. Chem. Int. Ed. 50 (2011) 5927-5931 doi: 10.1002/anie.201101009

  8. [8]

     R. Lai, X. Wu, S. Lv, et al., Chem. Commun. 55 (2019) 4039-4042 doi: 10.1039/c9cc01146c

  9. [9]

     X. Chen, M. Wang, X. Zhang, X. Fan, Org. Lett. 21 (2019) 2541-2545 doi: 10.1021/acs.orglett.9b00340

  10. [10]

      Y. Xu, X. Yang, X. Zhou, L. Kong, X. Li, Org. Lett. 19 (2017) 4307-4310 doi: 10.1021/acs.orglett.7b01974

  11. [11]

      B. Ramesh, M. Tamizmani, M.J. Jeganmohan, J. Org. Chem. 84 (2019) 4058-4071 doi: 10.1021/acs.joc.9b00051

  12. [12]

      S.T. Mei, H.W. Liang, B. Teng, et al., Org. Lett. 18 (2016) 1088-1091 doi: 10.1021/acs.orglett.6b00197

  13. [13]

      L. Shi, B. Wang, Org. Lett. 18 (2016) 2820-2823 doi: 10.1021/acs.orglett.6b01234

  14. [14]

      R. Chen, S. Cui, Org. Lett. 19 (2017) 4002-4005 doi: 10.1021/acs.orglett.7b01728

  15. [15]

      X. Wu, H. Xiong, S. Sun, J. Cheng, Org. Lett. 20 (2018) 1396-1399 doi: 10.1021/acs.orglett.8b00119

  16. [16]

      C. Zhou, J. Zhao, W. Guo, J. Jiang, J. Wang, Org. Lett. 21 (2019) 9315-9319 doi: 10.1021/acs.orglett.9b03357

  17. [17]

      W. Chen, F.X. Liu, W. Gong, et al., Adv. Synth. Catal. 360 (2018) 2470-2475 doi: 10.1002/adsc.201800322

  18. [18]

      D. Li, N. Xu, Y. Zhang, L. Wang, Chem. Commun. 50 (2014) 14862-14865 doi: 10.1039/C4CC06457G

  19. [19]

      Y. Wang, H. Zhou, K. Xu, M. Shen, H. Xu, Chin. Chem. Lett. 28 (2017) 92-96 doi: 10.1117/12.2285263

  20. [20]

      L. Wang, D. Xiong, L. Jie, C. Yu, X. Cui, Chinese Chem. Lett. 29 (2018) 907-910 doi: 10.1016/j.cclet.2018.05.007

  21. [21]

      H. Li, Y. Han, Z. Yang, Z. Yao, L. Wang, X. Cui, Chin. Chem. Lett. 32 (2021) 1263–1266 doi: 10.1016/j.cclet.2020.09.020

  22. [22]

      Y. Yu, Z. Xia, Q. Wu, D. Liu, L. Yu, Y. Xiao, Z. Tan, Deng, W.; Zhu, G., Chinese Chem. Lett. 32 (2021) 1263-1266 doi: 10.1016/j.cclet.2020.09.020

  23. [23]

      J. Zhang, J.S. Sun, Y.Q. Xia, L. Dong, Adv. Synth. Catal. 361 (2019) 2037-2041 doi: 10.1002/adsc.201801606

  24. [24]

      K. Muralirajan, R. Kuppusamy, S. Prakash, C.H. Cheng, Adv. Synth. Catal. 358 (2016) 774-783 doi: 10.1002/adsc.201501056

  25. [25]

      C.E. Gutteridge, M.M. Hoffman, A.K. Bhattacharjee, W.K. Milhous, L. Gerena, Bioorg. Med. Chem. Lett. 21 (2011) 786-789 doi: 10.1016/j.bmcl.2010.11.099

  26. [26]

      R. Saari, J. C. Torma, T. Nevalainen, Bioorg. Med. Chem. 19, (2011) 939-950 doi: 10.1016/j.bmc.2010.11.059

  27. [27]

      A.L. Smith, F.F. DeMorin, N.A. Paras, et al., J. Med. Chem. 52 (2009) 6189-6192 doi: 10.1021/jm901081g

  28. [28]

      N. Shelach, N. Lowenton-spier, Patent WO 2020165755 A1, 2020.

  29. [29]

      C. Rivalle, F. Wendling, P. Tambourin, et al., J. Med. Chem. 26 (1983) 181-185 doi: 10.1021/jm00356a012

  30. [30]

      C.G. Barber, R.P. Dickinson, P.V. Fish, Bioorg. Med. Chem. Lett. 14 (2004) 3227-3230 doi: 10.1016/j.bmcl.2004.03.094

  31. [31]

      I.H. Bae, J.B. Son, S.M. Han, et al., Patent WO 2013100632, 2013.

  32. [32]

      D.N. Rao, S. Rasheed, S. Aravinda, R.A. Vishwakarma, P. Das, RSC Adv. 3 (2013) 11472-11475 doi: 10.1039/c3ra40735g

  33. [33]

      B.K. Lee, M.R. Biscoe, S.L. Buchwald, Tetrahedron Lett. 50 (2009) 3672-3674 doi: 10.1016/j.tetlet.2009.03.137

  34. [34]

      C. Yang, F. Zhang, G.J. Deng, H. Gong, J. Org. Chem. 84 (2019) 181-190 doi: 10.1021/acs.joc.8b02588

  35. [35]

      X. Xie, T.Y. Zhang, Z. Zhang, J. Org. Chem. 71 (2006) 6522-6529 doi: 10.1021/jo060945k

  36. [36]

      D. Kim, P. Ghosh, N.Y. Kwon, et al., J. Org. Chem. 85 (2020) 2476-2485 doi: 10.1021/acs.joc.9b03173

  37. [37]

      X. Chen, X. Li, Z. Qu, et al., Adv. Synth. Catal. 356 (2014) 1979-1985 doi: 10.1002/adsc.201301065

  38. [38]

      W.Z. Bi, K. Sun, C. Qu, et al., Org. Chem. Front. 4 (2017) 1595-1600 doi: 10.1039/C7QO00311K

  39. [39]

      Y. Nanaji, S. Kirar, S.V. Pawar, A.K. Yadav, RSC Adv. 10 (2020) 7628-7634 doi: 10.1039/c9ra10397j

  40. [40]

      M. Couturier, L. Caron, S. Tumidajski, K. Jones, T. D. White, Org. Lett. 8 (2006) 1929-1932 doi: 10.1021/ol060473w

  41. [41]

      A.T. Londregan, S. Jennings, W. Liuqing, Org. Lett. 12 (2010) 5254-5257 doi: 10.1021/ol102301u

  42. [42]

      P.J. Manley, M.T. Bilodeau, Org. Lett. 4 (2002) 3127-3129 doi: 10.1021/ol0264556

  43. [43]

      L.Y. Xie, S. Peng, L.L. Jiang, et al., Org. Chem. Front. 6 (2019) 167-171 doi: 10.1039/c8qo01128a

  44. [44]

      S. Huang, H. Li, X. Sun, et al., Org. Lett. 21 (2019) 5570-5574 doi: 10.1021/acs.orglett.9b01902

  45. [45]

      Y. Li, C. Jia, H. Li, et al., Org. Lett. 20 (2018) 4930-4933 doi: 10.1021/acs.orglett.8b02057

  46. [46]

      Y. Li, Z. Qi, H. Wang, X. Yang, X. Li, Angew. Chem. Int. Ed. 55 (2016) 11877-11881 doi: 10.1002/anie.201606316

  47. [47]

      Z. Qi, S. Yu, X. Li, Org. Lett. 18 (2016) 700-703 doi: 10.1021/acs.orglett.5b03669

  48. [48]

      X. Song, Q. Zhou, J. Zhao, et al., Org. Lett. 22 (2020) 9506-9512 doi: 10.1021/acs.orglett.0c03515

  49. [49]

      F. Xu, Y. Song, W. Zhu, et al., Chem. Commun. 56 (2020) 11227-11230 doi: 10.1039/d0cc04885b

  50. [50]

      L. Xu, L. Wang, Y. Feng, et al., Org. Lett. 19 (2017) 4343-4346 doi: 10.1021/acs.orglett.7b02028

  51. [51]

      J. Zhou, J. Li, Y. Li, et al., Org. Lett. 20 (2018) 7645-7649 doi: 10.1021/acs.orglett.8b03383

  52. [52]

      X. Zhou, Z. Qi, S. Yu, et al., Adv. Synth. Catal. 359 (2017) 1620-1625 doi: 10.1002/adsc.201601278

  53. [53]

      J. Ren, Y. Huang, C. Pi, X. Cui, Y. Wu, Chin. Chem. Lett. 32 (2021) 2592–2596. doi: 10.1016/j.cclet.2021.02.061

  54. [54]

      J. Li, Z. Zhang, M. Tang, X. Zhang, J. Jin, Org. Lett. 18 (2016) 3898-3901 doi: 10.1021/acs.orglett.6b01916

  55. [55]

      Y. Zuo, X. He, Y. Ning, Y. Wu, Y. Shang, J. Org. Chem. 83 (2018) 13463-13472 doi: 10.1021/acs.joc.8b02286

  56. [56]

      J. Li, M. Tang, L. Zang, et al., Org. Lett. 18 (2016) 2742-2745 doi: 10.1021/acs.orglett.6b01199

  57. [57]

      Q. Yang, C. Wu, J. Zhou, et al., Org. Chem. Front. 6 (2019) 393-398 doi: 10.1039/c8qo01148f

  58. [58]

      C. Li, H.B. Xu, J. Zhang, M. Liu, L. Dong, Org. Biomol. Chem. 18 (2020) 1412-1416 doi: 10.1039/c9ob02553g

  59. [59]

      J. Li, M. John, L. Ackermann, Chem. Eur. J. 20 (2014) 5403-5408 doi: 10.1002/chem.201304944

  60. [60]

      X. Wei, M. Zhao, Z. Du, X. Li, Org. Lett. 13 (2011) 4636-4639 doi: 10.1021/ol2018505

  61. [61]

      G. Zheng, M. Tian, Y. Xu, X. Chen, X. Li, Org. Chem. Front. 5 (2018) 998-1002 doi: 10.1039/C7QO01033H

  62. [62]

      C. Wu, J. Zhou, G. He, et al., Org. Chem. Front. 6 (2019) 1183-1188 doi: 10.1039/c9qo00048h

  63. [63]

      K. Ghosh, Y. Nishii, M. Miura, ACS Catal. 9 (2019) 11455-11460 doi: 10.1021/acscatal.9b04254

  64. [64]

      K. Ghosh, Y. Nishii, M. Miura, Org. Lett. 22 (2020) 3547-3550 doi: 10.1021/acs.orglett.0c00975

  65. [65]

      Y. Nishii, M. Miura, ACS Catal. 10 (2020) 9747-9757 doi: 10.1021/acscatal.0c02972

  66. [66]

      Z.H. Wang, H. Wang, H. Wang, L. Li, M.D. Zhou, Org. Lett. 23 (2021) 995-999 doi: 10.1021/acs.orglett.0c04200

  67. [67]

      X. Li, T. Huang, Y. Song, et al., Org. Lett. 22 (2020) 5925-5930 doi: 10.1021/acs.orglett.0c02016

  68. [68]

      G. Mihara, K. Ghosh, Y. Nishii, M. Miura, Org. Lett. 22 (2020) 5706-5711 doi: 10.1021/acs.orglett.0c02112

• 

  Figure 1  Selected examples of bioactive aminoisoquinolines.

  下载: 全尺寸图片 幻灯片
  

  Scheme 1  Synthesis of aminoisoquinolines and other heterocycles via C-H activation/annulation.

  下载: 全尺寸图片 幻灯片
  

  Scheme 2  Substrate scope of benzamidines. Reaction conditions: 1 (0.2 mmol), 2a (0.4 mmol), [Cp*RhCl₂]₂ (5 mol%), AgOTf (20 mol%), KOPiv (20 mol%), Toluene (1.5 mL), Ar, 100 ℃, 24 h.

  下载: 全尺寸图片 幻灯片
  

  Scheme 3  Substrate scope of N-phenylbenzimidamides.

  下载: 全尺寸图片 幻灯片
  

  Scheme 4  Ten-fold-scale synthesis of aminoisoquinolines.

  下载: 全尺寸图片 幻灯片
  

  Scheme 5  Mechanistic studies.

  下载: 全尺寸图片 幻灯片
  

  Scheme 6  Plausible reaction mechanism.

  下载: 全尺寸图片 幻灯片

  Table 1.  Optimization of reaction conditions.^a

  下载: 导出CSV
•